Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
14.6M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$11.2M
-
Value change
-
-$3.08M
-
Number of buys
-
12
-
Number of sells
-
-19
-
Price
-
$0.77
Significant Holders of NextCure, Inc. - Common Stock (NXTC) as of Q4 2024
51 filings reported holding NXTC - NextCure, Inc. - Common Stock as of Q4 2024.
NextCure, Inc. - Common Stock (NXTC) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.6M shares
of 28M outstanding shares and own 52.01% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (2.67M shares), Affinity Asset Advisors, LLC (2.3M shares), CITIGROUP INC (1.39M shares), ORBIMED ADVISORS LLC (1.14M shares), VANGUARD GROUP INC (987K shares), BlackRock, Inc. (728K shares), TANG CAPITAL MANAGEMENT LLC (700K shares), Cable Car Capital, LP (616K shares), RENAISSANCE TECHNOLOGIES LLC (519K shares), and ACADIAN ASSET MANAGEMENT LLC (488K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.